We considered patients with and without pathogenetic GRN mutations, to assess the role of cognitive reserve in monogenic inherited disease, and asymptomatic subjects carrying GRN mutations, to evaluate how cognitive reserve acts on functional neuronal networks almost twenty years before the disease onset. This evidence concerns the gene GRN and hereditary disease.